Literature DB >> 1377084

Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens.

T Nitta1, K Sato, M Allegretta, S Brocke, M Lim, D J Mitchell, L Steinman.   

Abstract

Expression of granulocyte (G) and granulocyte-macrophage (GM) colony stimulating factor (CSF) genes in human cells of astroglial lineage was studied. Primers for CSFs were used to analyze RNA transcripts in 5 cultured human astrocytoma cell lines and 8 fresh brain specimens by polymerase chain reaction. Constitutive expression of mRNA transcripts of GM-CSF could be detected in all astrocytoma and one neuroblastoma cell lines, and two out of 5 unstimulated astrocytomas, U87MG and U138 MG, expressed G-CSF genes. After stimulation with interleukin (IL)-1 beta + tumor necrosis factor (TNF)-alpha, all cell lines expressed G-CSF. In addition to the cultured cells, we examined gene expression within human malignant astrocytoma, peritumoral brain and autopsied normal brains. The results show that some of the tumor and its surrounding reactive lesions express G- and GM-CSF genes but normal brains do not. The concentration of G- and GM-CSF in supernatants of cultured cells was assessed at the protein level by ELISA. A low level of GM-CSF activity was constitutively present in all astrocytomas. G-CSF was detected in unstimulated U87MG and U138MG and other cell lines could synthesize G-CSF after the stimulation of IL-1 beta and TNF-alpha at the level of mRNA. Furthermore, the concentration of CSFs increased markedly upon stimulation with IL-1 beta and/or TNF-alpha in both a time- and dose-dependent fashion. From these results, it is suspected that astroglial cell-derived CSFs may participate in local immune reactions accompanying infection, degeneration and malignancies in the brain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377084     DOI: 10.1016/0006-8993(92)90505-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.

Authors:  Kien Pham; Defang Luo; Che Liu; Jeffrey K Harrison
Journal:  J Neuroimmunol       Date:  2012-03-16       Impact factor: 3.478

2.  Distribution of granulocyte-monocyte colony-stimulating factor and its receptor α-subunit in the adult human brain with specific reference to Alzheimer's disease.

Authors:  Sami Ridwan; Henrike Bauer; Katrin Frauenknecht; Harald von Pein; Clemens J Sommer
Journal:  J Neural Transm (Vienna)       Date:  2012-03-20       Impact factor: 3.575

3.  Microglia/macrophages promote glioma progression.

Authors:  Haiyan Zhai; Frank L Heppner; Stella E Tsirka
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

4.  Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression.

Authors:  M M Mueller; C C Herold-Mende; D Riede; M Lange; H H Steiner; N E Fusenig
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  A panel of four cytokines predicts the prognosis of patients with malignant gliomas.

Authors:  Yi Lin; Guozhen Zhang; Jing Zhang; Guangzu Gao; Min Li; Yong Chen; Jiangfei Wang; Guilin Li; Sonya-Wei Song; Xiaoguang Qiu; Yunjie Wang; Tao Jiang
Journal:  J Neurooncol       Date:  2013-06-08       Impact factor: 4.130

6.  Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression.

Authors:  Rui Pedro Galvão; Hui Zong
Journal:  Curr Pathobiol Rep       Date:  2013-03-01

Review 7.  Cytokine gene expression within the central nervous system.

Authors:  T Nitta
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

8.  Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients.

Authors:  Andre N Gay; Shirong Chang; Lindsey Rutland; Ling Yu; Sarah Byeseda; Bindi Naik-Mathuria; Darrell L Cass; Heidi Russell; Oluyinka O Olutoye
Journal:  J Pediatr Surg       Date:  2008-05       Impact factor: 2.545

Review 9.  T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment.

Authors:  Darwin Kwok; Hideho Okada
Journal:  J Neurooncol       Date:  2020-03-17       Impact factor: 4.130

Review 10.  The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression.

Authors:  Belinda Yeo; Andrew D Redfern; Kellie A Mouchemore; John A Hamilton; Robin L Anderson
Journal:  Clin Exp Metastasis       Date:  2018-07-02       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.